HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2019-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Crestone, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93020C00020 Federal contract award
Notice details come from SAM.gov. Updated .
About this opportunity
Crestone Inc. was awarded a contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to support Research Area 002, which focuses on developing therapeutic products for antibiotic resistant bacteria. The contract value awarded to Crestone Inc. on February 2, 2021 is $18,190446.00 to advance this important research area aimed at combating antibiotic resistant bacteria through the development of new therapeutic solutions over the period of performance.
Notice text
Awarded contract 75N93020C00020 to CRESTONE INC for 18190446.00 on 2020-06-29.
Notice history
| Notice | Type | Posted |
|---|---|---|
| HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | Award Notice | |
| HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | Award Notice | |
| This notice | Award Notice | |
| HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria | Award Notice | |
| 2019 NIAID Omnibus Broad Agency Announcement | Pre-Solicitation | |
| 2019 NIAID Omnibus Broad Agency Announcement | Special Notice |
6 of 11 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity